Search Results
Results found for "Haicang Zhang"
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
coupled receptors under diverse states Fan Liu , Han Zhou , Xiaonong Li , Liangliang Zhou , Chungong Yu , Haicang Zhang , Dongbo Bu 🤩 Seriously, why would you want to miss out on all the awesomeness that comes with
- Decoding Olfactory GPCRs: How AlphaFold and AI Are Changing the Game
Watch Episode 171 What happens when your protein has no known ligands, no structure, and very little data? For most researchers, that’s a dead end. For Alessandro Nicoli, it’s an opportunity. In this post, we explore how computational tools—especially AlphaFold —are helping crack the mystery of olfactory GPCRs , one of the most elusive receptor families in the human body. The Problem: Hundreds of Receptors, Almost No Ligands Alessandro’s work focuses on olfactory GPCRs—nearly 400 distinct receptors that play key roles in smell but remain largely uncharacterized . Most have only one known ligand, if any. Their structures are hard to determine experimentally due to poor expression and the volatility of odorant molecules. That’s where computational chemistry steps in. Enter AlphaFold: Predicting the “Face” of a Receptor When Alessandro began his PhD, structural models of olfactory GPCRs were essentially nonexistent. The main challenge was simple but daunting: “The challenge was to get a face to those proteins—the structure. AlphaFold has, of course, as we know, revolutionized the world.” —Alessandro Nicoli For the first time, researchers had a reliable set of predicted structures to work from. That meant simulations, ligand screening, and experimental design could move forward with confidence. “When they released the first structure of the odorant receptors… AlphaFold already had it, without any prior information, and the match was very close to experimental error.” —Alessandro Nicoli A New Era of GPCR Research AlphaFold didn’t just fill a gap—it shifted the focus of computational biology. Instead of struggling to predict structures from scratch, Alessandro and others could now use AI-generated models as starting points for deeper questions. “…now you have a plethora of 400 models that you can start with molecular dynamics, docking, virtual screening.” —Alessandro Nicoli The result? More accurate hypotheses, faster ligand discovery, and new strategies to tackle one of biology’s most complex receptor families. From Prediction to Discovery One of Alessandro’s projects focused on receptor R5VK1 , where his team tested computational models against a set of experimentally validated active and inactive ligands. By iteratively refining the models with docking and mutagenesis data, they developed predictive pipelines that can help identify new odorant ligands . This case study highlights why computational chemistry is no longer a side tool—it’s a driver of discovery , especially when experimental data is scarce. Want to level up your modeling skills? Start with our GPCR training program and get hands-on with virtual tools shaping the future of drug discovery. ________ Keyword Cloud: # AlphaFold #GPCRdata #DrugDiscovery #OlfactoryReceptors #StructuralBiology #ArtificialIntelligence #MolecularDynamics #ComputationalBiology #MolecularModeling
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
allosteric modulators with built-in selectivity and context sensitivity Why GPCR Allosteric Thinking Changes Ligands don’t just “bind”—they change the receptor. These changes can alter how the receptor talks to G proteins, arrestins, or other receptors. muscarinic receptors, CCR5 chemokine programs, and NMDA receptors, where ligand context fundamentally changes But without understanding how GPCR state changes influence that affinity—or vice versa—drug discovery
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
April 2022 Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage Sosei Group Corporation (“the Company”; TSE: 4565) today confirms that a series of Executive Management changes
- Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for ...
Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for metabolic
- Fluorescence Polarization in GPCR Research
Adapted from: Zhang Y, Tang H, Chen W, Zhang J. is most effective at studying interactions between large proteins and small ligands thanks to this change
- β-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the...
associate with the active parathyroid hormone 1 receptor (PTH1R) in different complex configurations ("hanging Moreover, we assess β-arrestin conformational changes that are induced specifically by proximal and distal Here, we show differences between conformational changes that are induced by P-R* or R* receptor states
- Structural landscape of the Chemokine Receptor system
Conformational changes between inactive and active states are facilitated by a "microswitch network" chemokine antagonist ([5P7]CCL5), and a small-molecule inverse agonist (maraviroc) (Tan, Zhu et al. 2013, Zheng , Han et al. 2017, Isaikina, Tsai et al. 2021, Zhang, Chen et al. 2021). , exhibits bias toward G-protein signaling, which has been structurally related to a conformational change
- Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025
Xiaoyu Zhang showed great insight into new ligands for new E3 ligases for PROTAC development.
- VAMP2: a crucial player in the delivery of MOR to the synapse
Zhang, A.J.M. Molina, T.C. Südhof, and R.C. Malenka. 2013. Zhang, and L. Ma. 2008.
- Understanding the Journey: Catherine Demery's Path to Addiction Science
While her work there focused on immunological changes in pregnancy—not addiction—it was a valuable chapter Catherine's experience serves as a reminder that it is never too late to change direction and pursue Embracing Change and Uncertainty Change can be daunting, especially when it involves stepping away from illustrates the power of following one's passion and the importance of being adaptable in the face of change Catherine's experience serves as an inspiration for anyone considering a career change or seeking to
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
the lipid composition of intracellular membranes may influence GPCR dynamics and signaling outcomes, changing Z., Wilderman, A., Katakia, T., McCann, T., Yokouchi, H., Zhang, L., Corriden, R., Liu, D., Feigin, M
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
These receptors respond to a variety of signals by undergoing structural changes that activate internal brief sequential intervals following GTP addition, the research team identified the conformational changes The captured structures reveal a dynamic of conformational changes initiated by the binding of an agonist This early interaction sets the stage for a cascade of significant conformational changes. Concurrently, the α1 helix extends, propagating structural changes throughout the G protein.
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
This process is a binding event that facilitates a change in the shape of a macromolecule which impacts post-translational modification, or protein interactions, allowing proteins to sense and respond to changes structure, its molecular interactions with various ligands and canonical Gαq transducer, and conformational changes Lu S, He X, Ni D, Zhang J.
- Overview of adhesion GPCRs self-activation
structural perspective, the -4 position of αH5 was key for the selectivity of G-protein coupling, since the change , Z., Liu, C., Li, X., Zhu, X., Wang, N., Xu, Z., Xia, R., Liang, J., Duan, Y., Yin, H., Xiong, Y., Zhang
- Innovative Data-Driven Solutions: The pHSense Revolution
These probes shift brightness and fluorescence lifetime as pH changes. “You’re not changing the spectrum. You’re just changing how bright it is—and how long it glows,” said Dr. Eric Trinquet. To hear the full story of how pHSense came to life—and why the GLP-1 data changed everything— 🎧 Listen
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
Mutagenesis involves deliberately altering the DNA sequence of a gene to study the resulting changes framework that combined mutagenesis and structural data to contextualise ligand-induced structural changes datasets, allowing researchers to determine the functional consequences of every possible amino acid change ligand-receptor interactions, mutagenesis fills crucial knowledge gaps by revealing how specific amino acid changes B., Chang, B., & Peisajovich, S. G. (2017).
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
Zhang, H., et al., Autocrine selection of a GLP-1R G-protein biased agonist with potent antidiabetic
- From Venice to Virtual Molecules: Alessandro Nicoli’s Unexpected Journey into Computational Chemistry
But one academic spark—and the right mentor—changed his trajectory forever. —Alessandro Nicoli This perspective changed everything.
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
Kenakin’s latest lecture delivers a game-changing framework for teams grappling with the gap between This lecture is a guide to understanding why intracellular drug access changes everything: from target scaffold permeability using modern, cost-effective pharmacokinetic assays Why Intracellular GPCR Drugs Change
- Is Your Agonist Really “Working”—Or Are You Just Seeing What Your System Allows?
In this eye-opening module, Terry Kenakin explores a concept that could change how you interpret pharmacological
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
lanthanide probes, the team realized they could tune these molecules to become exquisitely sensitive to pH changes : Endogenous GLP-1 internalization shown in beta cells 🚀 2025: Revvity launches pHSense A Day That Changed questions about constitutive activity, agonist-induced internalization, and cellular dynamics. 🔄 What Changed
- Understanding Orthosteric Binding: The Key to Drug Action
. 📚 Whether you're new to pharmacology or brushing up on basics, this lesson will change how you think The receptor may change shape upon binding, affecting how the drug interacts and how effective it will
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Medicinal Chemistry 2020 , 188 , 112037. https://doi.org/10.1016/j.ejmech.2020.112037 . (15) Zhang Discovery 2010 , 15 (10), 1248–1259. https://doi.org/10.1177/1087057110384611 . (25) Fulp, A.; Zhang
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
Fluorescence Anisotropy and BBV – The theory behind the assays FA is based on measuring the change in Figure 1.Time course of FA change caused by CELT-419 binding to D3 receptor on the BBV particles. The insert shows the Log(IC50) ± SE change in time of corresponding displacement curves. The Log(IC50) change in time was fitted with equation 3 and k given is the weighted average from 3 H.; Bates, M.; Zhuang, X.
- Therapeutic validation of an orphan G protein‐coupled receptor
these ligands are orthosteric agonists such as alkylpyrimidine‐4,6‐diol derivatives (Liu et al., 2016; Zhang
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
Allosteric sites operate differently: ligands bind elsewhere, transmit energy changes, and shift the How Conformational Changes Drive Affinity and Efficacy A key takeaway from this session: affinity and That’s where Terry’s Corner changes the game.
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
neuromodulator, neurotransmitter, etc.), binds to the extracellular binding site of the GPCR, the protein changes the β2 adrenergic receptor (β2AR; PDB ID: 2RH1); (B) A ligand-bound GPCR undergoes a conformational change The conformation change induced by the agonist may not always lead to the same intracellular signaling
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
Ramona Birke , Joshua Levitz , Ben Jones , Johannes Broichhagen Design of allosteric modulators that change This change is all about keeping our community strong and delivering top-notch content. the discovery of antibodies, which recognized native receptor Design of allosteric modulators that change predicted by combinatorial computational strategy Uncovering conserved networks and global conformational changes
- 📰 GPCR Weekly News, April 29 to May 5, 2024
announcements in today’s episode, so join us in this celebration and be the first to know about all the changes




















